Conditions: HIV
Keywords: maraviroc naive hiv zidovudine lamivudine combivir Clade A
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 98
Healthy volunteers: no

Brief summary:
One hundred subjects in Russia will be treated with a combination of Combivir (zidovudine and lamivudine) and maraviroc as their first line HIV therapy. The aim is to assess the efficacy and safety of this combination in a Russian population of patients.

Detailed description:

Arms:
arm 1: Single arm study of combivir and maraviroc for 48 weeks

Interventions: intervention 1: HIV therapy
Intervention descriptions: intervention 1: Combivir one tablet BD with maraviroc 300mg BD for 48 weeks

Protocol document: